By End-Use Application

Biotechnology & CRO/CDMO Market Analysis

Cross-industry research covering Biotechnology & CRO/CDMO across 1 market reportspanning Semiconductor & Electronics / Life Science Instrumentation.

1 Reports

1 Industries

Reports Covering Biotechnology & CRO/CDMO

Protein Gel Macromolecular Imagers Market to Reach USD 1.82B by 2033 at 6.4% CAGR

Semiconductor & Electronics / Life Science Instrumentation·Market: USD 1.10 Billion (2025)·CAGR: 6.4%

Contract research and development/manufacturing organizations are a high-growth end-use segment as outsourced biologics development accelerates. CRO/CDMOs require audit-ready quantitative documentation, which favors software-validated fluorescence imaging platforms over legacy CL darkroom methods. Danaher's Cytiva, operating within a USD 24.57B revenue base, is well-positioned to capture this segment via bundled bioprocess and analytics offerings (edgar:DHR-10K-2025).

16%

Market Share

7.8%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments